BTG Pactual Global Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

BTG Pactual Global Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$1.09M	Buy	+9,579	New	+$1.31M	0.18%	101
2019 Q3	–	Sell	-4,890	Closed	-$533K	–	65
2019 Q2	$533K	Buy	+4,890	New	+$520K	0.13%	55
2018 Q1	–	Sell	-14,833	Closed	-$1.58M	–	72
2017 Q4	$1.58M	Buy	+14,833	New	+$1.59M	0.58%	30

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

BTG Pactual Global Asset Management's IBB Position: Q1 2024 in Review

BTG Pactual Global Asset Management opened a new position in iShares Biotechnology ETF (IBB) in Q1 2024: 9,579 shares worth $1.09M. The stake represents 0.18% of the portfolio and ranks #101 among its holdings. This is a return to the name: BTG Pactual Global Asset Management previously reported a position in IBB as recently as Q2 2019.

BTG Pactual Global Asset Management first reported a position in IBB in Q4 2017 and has held it in 3 quarters since. The position peaked at $1.58M in Q4 2017. 899 funds tracked by Wall St. Rank hold IBB as of Q1 2024.

BTG Pactual Global Asset Management held 9,579 shares of iShares Biotechnology ETF worth $1.09M as of Q1 2024.
iShares Biotechnology ETF was a new BTG Pactual Global Asset Management position in Q1 2024.
iShares Biotechnology ETF made up 0.18% of BTG Pactual Global Asset Management's portfolio in Q1 2024, its #101 holding.
BTG Pactual Global Asset Management first reported a position in iShares Biotechnology ETF in Q4 2017 and has held it in 3 quarters since.
BTG Pactual Global Asset Management's iShares Biotechnology ETF position peaked at $1.58M in Q4 2017.
899 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2024.

Based on BTG Pactual Global Asset Management's 13F filing for Q1 2024, filed 15 May 2024.